Literature DB >> 6784438

Confusion, myoclonus and speech arrest: epileptic manifestations after metrizamide myelography.

U Bergvall, T Brismar, U Lying-Tunell, E Valdimarsson.   

Abstract

The importance of accurate diagnosis of epileptic manifestations, even if unusual, as complications of diagnostic metrizamide exploration of the CSF space is emphasized on the basis of 2 case histories.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6784438     DOI： 10.1111/j.1600-0404.1981.tb00785.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


  3 in total

1.  Influence of the spread and period of retention of Iotrolan in the subarachnoid space on the side effects rate in myelography.

Authors:  B Hoffmann; H Becker; B I Wenzel-Hora
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

2.  Non-ionic water soluble contrast medium 3-deoxy-3-iodo-D-glucose (DIG) for use in the CSF space. An experimental study with mongrel and beagle dogs.

Authors:  S Suzuki; K Ebina; T Sekiya; T Iwabuchi
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

3.  Metrizamide and the EEG: three case reports and a review.

Authors:  M Elian; P Fenwick
Journal:  J Neurol       Date:  1985       Impact factor: 4.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.